New! Sign up for our free email newsletter.
Science News
from research organizations

Candida evolution disclosed: New insights into fungal infections

Date:
January 14, 2024
Source:
Institute for Research in Biomedicine (IRB Barcelona)
Summary:
Identification of genes under recent selection provides insights into the molecular mechanisms of human-related adaptation in Candida pathogens. The study reveals both known and novel genetic variants associated with drug resistance, offering potential targets for improved antifungal therapies.
Share:
FULL STORY

Global fungal infections, which affect one billion people and cause 1.5 million deaths each year, are on the rise due to the increasing number of medical treatments that heighten vulnerability. Patients undergoing chemotherapy or immunosuppressive treatments after organ transplant often present compromised immune systems. Given the emergence of resistant strains, the limited variety of current antifungal drugs as well as their cost and side effects, the treatment of these infections is challenging and brings about an urgent need for more effective treatments.

In this context, a team from the Institute for Research in Biomedicine (IRB Barcelona) and the Barcelona Supercomputing Center -- Centro Nacional de Supercomputación (BSC-CNS), led by the ICREA researcher Dr. Toni Gabaldón, has identified hundreds of genes subject to recent, clinically-relevant selection in six species of the fungal pathogen Candida.

"This work highlights how thesepathogens adapted to humans and antifungal drugs and provides valuable knowledge that could lead to better treatments for Candida infections," explains Dr. Gabaldón, head of the Comparative Genomics lab at IRB Barcelona and the BSC.

More than 2,000 genomes from 6 different species

The study delves into the evolutionary landscape of Candida pathogens by analysing approximately 2,000 genomes from clinical samples of six major Candida species. These genomes are stored in public databases. The researchers compared these genomes to a reference, creating a comprehensive catalogue of genetic variants.

Building on previous work addressing drug-resistant strains, the researchers conducted a Genome-Wide Association Study (GWAS) to identify genetic variants linked to antifungal drug resistance in clinical isolates. This approach provided insights into both known and novel mechanisms of resistance towards seven antifungal drugs in three Candida species. "Additionally, a concerning finding has arisen from the study: the potential spread of resistance through mating between susceptible and resistant strains, contributing to the prevalence of drug-resistant Candida pathogens," explains Dr. Miquel Àngel Schikora-Tamarit, a postdoctoral researcher in the same lab and first author of the study.

In addition, by focusing on variants acquired recently among clinical strains, the researches detected shared and species-specific genetic signatures of recent selection that inform on which adaptations might be needed to thrive and spread in human-related environments.

Beyond the novel insights into the adaptation of Candida, the study provides a valuable resource, namely a comprehensive catalogue of variants, selection signatures, and drivers of drug resistance. This knowledge not only contributes to our understanding of these infections but also lays the groundwork for future experiments and potential advancements in the development of more effective treatments for Candida infections.

This work was funded by the Spanish Ministry of Science, Innovation and Universities, The European Research Council, and "la Caixa" Foundation.


Story Source:

Materials provided by Institute for Research in Biomedicine (IRB Barcelona). Note: Content may be edited for style and length.


Journal Reference:

  1. Miquel Àngel Schikora-Tamarit, Toni Gabaldón. Recent gene selection and drug resistance underscore clinical adaptation across Candida species. Nature Microbiology, 2024; 9 (1): 284 DOI: 10.1038/s41564-023-01547-z

Cite This Page:

Institute for Research in Biomedicine (IRB Barcelona). "Candida evolution disclosed: New insights into fungal infections." ScienceDaily. ScienceDaily, 14 January 2024. <www.sciencedaily.com/releases/2024/01/240114212058.htm>.
Institute for Research in Biomedicine (IRB Barcelona). (2024, January 14). Candida evolution disclosed: New insights into fungal infections. ScienceDaily. Retrieved February 22, 2024 from www.sciencedaily.com/releases/2024/01/240114212058.htm
Institute for Research in Biomedicine (IRB Barcelona). "Candida evolution disclosed: New insights into fungal infections." ScienceDaily. www.sciencedaily.com/releases/2024/01/240114212058.htm (accessed February 22, 2024).

Explore More
from ScienceDaily

RELATED STORIES